Chicago, IL (PRWEB) September 10, 2014
Research Down Syndrome (RDS) has announced funding for six grants to support Down syndrome cognitive research.
RDS is committed to supporting the identification of the causes of the intellectual impairments associated with Down syndrome and to facilitating the development of pharmacological therapies to improve memory, learning and communication in persons with Down syndrome. RDS supported research is also aimed at developing drug treatments that might limit the impact of Alzheimer’s disease in persons with Down syndrome. Encouraging progress has been made over a very short time. Three human clinical trials to test potential drug treatments are underway, and a fourth is being planned. This is less than a decade after the support of private foundations stimulated the progress of Down syndrome cognitive research.
Research Down Syndrome prioritizes funding towards programs with a high probability of readily contributing to the development of safe and effective therapies. Continued private donations are needed to support the constantly expanding research efforts that will lead to potential medical treatments.
The 2014/2015 RDS Research Grants include:
Johns Hopkins University School of Medicine: RDS Research Center Grant entitled “A Down Syndrome Center for Fundamental Research"
Emory School of Medicine and Research Network Consortium: RDS Research Grant entitled “The Down Syndrome Cognition Project”
University of California, San Diego School of Medicine: RDS Research Center Grant entitled “Defining the Genes and Mechanisms and Treatments for Neurodegenerative Causes of Cognitive Dysfunction in Down Syndrome”
University of Arizona: RDS Research Grant entitled “The Neuropsychology of Down Syndrome”
Stanford University School of Medicine: RDS Research Grant entitled “Mechanisms Underlying the Roles of Sleep and Circadian Rhythms in the Learning Disability of Down Syndrome”
VA Palo Alto Health Care System: RDS Research Pilot Grant entitled “Improving Adrenergic Signaling for the Treatment of Cognitive Dysfunction in Down Syndrome”
Detailed information on these grants can be found here.
About Research Down Syndrome
Research Down Syndrome (RDS) is among the leading sources of private funding for Down syndrome related cognitive research. RDS supports and funds Down syndrome cognitive research conducted at research institutions that are studying the basis of the intellectual impairments associated with Down syndrome, including Alzheimer's disease. Research Down Syndrome is a legal corporate entity, and is a 501(c) (3) nonprofit organization designated by the Internal Revenue Code. For more information, go to http://www.researchds.org, or contact RDS: info(at)researchds(dot)org or 847.710.2251.